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Abstract 
Background: Medication errors (MEs) are important problems in all hospitalized populations, especially in intensive 
care unit (ICU). Little is known about the prevalence of medication prescribing errors in the ICU of hospitals in Ethio-
pia. The aim of this study was to assess medication prescribing errors in the ICU of Tikur Anbessa Specialized Hospital 
using retrospective cross-sectional analysis of patient cards and medication charts.
Results: About 220 patient charts were reviewed with a total of 1311 patient-days, and 882 prescription episodes. 
359 MEs were detected; with prevalence of 40 per 100 orders. Common prescribing errors were omission errors 154 
(42.89 %), 101 (28.13 %) wrong combination, 48 (13.37 %) wrong abbreviation, 30 (8.36 %) wrong dose, wrong fre-
quency 18 (5.01 %) and wrong indications 8 (2.23 %).
Conclusions: The present study shows that medication errors are common in medical ICU of Tikur Anbessa Special-
ized Hospital. These results suggest future targets of prevention strategies to reduce the rate of medication error.
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Background
Pharmaceutical care is the responsible provision of drug 
therapy for the purpose of achieving definite outcomes 
that improve patients’ quality of life. Any suboptimum 
therapy leads to medication error [1]. Medication errors 
(MEs) are defined as any preventable event that may 
cause or lead to an inappropriate medication usage, or 
harms the patient, while in the control of the health care 
professional, patient or consumer. Errors in the medica-
tion process can occur at different stages: prescribing, 
transcribing, dispensing and administration [2].
Medication errors are one of the most common types 
of medical errors and one of the most common and pre-
ventable causes of iatrogenic injuries [3]. These events 
may occur due to professional practice, health care 
products, and procedures such as prescribing, dispens-
ing, and administration. High error rates with serious 
consequences are most likely to occur in intensive care 
units (ICUs) but errors are minimized in the presence of 
intensivists [4, 5]. Various studies have been carried out 
to find out the impact of MEs; but the issue received max-
imum attention in the immediate years after the Institute 
of Medicine (IOM) report 1999 was published [1]. This 
was followed with considerable interest by the medical 
community. However, to date, there is little evidence that 
patient safety has improved [6]. In general, some units 
such as ICUs are more prone to errors, because of com-
plex settings and medical conditions of patients [2].
Prescribing errors in critical care units are frequent, 
serious, and expected, since these patients are prescribed 
twice as many medications as patients outside criti-
cal care [5]. In the ICU, on average, patients experience 
1.7 errors per day and nearly all suffer a potentially life 
threatening error at some point during their stay than 
patients in other hospital wards due to their decreased 
physiological reserves which increase the risks of harm 
from medication-related errors. However, there is wide 
variation in the definition of errors and the methods used 
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to detect them [4, 5, 7]. MEs account for 78 % of serious 
medical errors in the ICU [6]. Factors contributing to 
the frequency of MEs include: unobtainable medical his-
tory, since most patients in the ICU are sedated, multiple 
medications being received, most medications in the ICU 
being given intravenously, where calculation of infusion 
rates is often required; and insufficient staff numbers [4, 
5, 8]. For these reasons, literature has long supported the 
concept of ‘pharmacist participation’ in the prescribing 
stage of medication orders, aiming to reduce the number 
of prescribing errors [9, 10]. Few epidemiological data 
are available regarding the prevalence, type and causes of 
MEs in ICUs of developing countries including Ethiopia. 
This study focused on prescribing errors because, pre-
scription is hand written and susceptible to error during 
prescription writing process and the absence of any sys-
tem to support prescribing physicians, who usually rely 
on their memory, to ensure correct prescribing practice. 
The objective of study was to assess medication prescrib-
ing errors rate in the ICU Tikur Anbessa Specialized 
Hospital (TASH), a tertiary care teaching hospital found 
in Addis Ababa, Ethiopia.
Methods
Study area
This study was conducted in the medical ICU of TASH. 
It is the largest specialized hospital in Ethiopia, provides 
a tertiary level referral treatment, with over 700 beds, and 
serves as the training center for undergraduate and post-
graduate medical students, dentists, nurses, midwives, 
pharmacists, medical laboratory technologists, radiol-
ogy technologists, and others who shoulder the health 
problems of the community and the country at large. The 
medical ICU has six beds and serves critically ill patients 
from different departments of the hospital.
Study design
A retrospective cross-sectional study was conducted 
from April 15 to May 15, 2013 by using charts of patients 
who were admitted in the medical ICU of TASH in the 
1 year period (March 1, 2012 to March 30, 2013).
Inclusion and exclusion criteria
All medication-prescribing interventions by all prescrib-
ing physicians for patients admitted to the medical ICU 
of TASH during the 1  year period were included in the 
study. Patients with age >12, irrespective of diagnosis, 
and gender all who were admitted in the medical ICU in 
the 1  year period and given medication were included. 
Patient cards and medication charts with missed vari-
ables, incomplete information, lost cards and with no 
medication order were excluded from the study.
Sample size determination
The sample size was calculated using single proportion 
formula and adjusted sample size was finally calculated 
using a prevalence value of 0.52 from previous study 
which results in sample size of 220. The sampling frame 
was obtained from patient registration form, which is all 
patients who were admitted to the medical ICU of TASH 
in the last 1 year period, and then random sampling tech-
nique was used to select subjects until 220 charts were 
obtained.
Study variables
Prescribing error was the dependent variable and co-
morbidities, age, state of the patient at admission, poly-
pharmacy, length of ICU stay, route of administration, 
experience of prescriber were independent variables.
Data collection and analysis
Data were collected, using a structured format, by two 
pharmacy practice postgraduate students who were 
trained on how to obtain data from patient cards and 
medication charts. The content includes demographic 
variables, dates and times of prescription, name of the 
medications, dosage forms, doses and frequency of medi-
cations prescribed. The clinical findings, the laboratory 
and diagnostic results were used to determine appro-
priate medications. Prescribing errors that could be 
identified with chart review alone were determined by 
comparing prescribed drugs with up-to-date standard 
treatment guidelines, textbooks, and software [11–14].
Data were edited, coded, and entered into SPSS (Win-
dows v 16.0). Descriptive statistics was computed to 
determine the overall prevalence of prescribing errors 
and logistic regression was generated to determine risk 
factors. The results were expressed as mean ±  standard 
deviation, median and/or percentage as appropriate. The 
p values less than 0.05 were considered significant.
Potential clinical consequences
A four-scale unambiguous classification system was 
developed including the following categories—poten-
tially fatal, potentially serious, potentially significant, 
and potentially non-significant. Definitions of potentially 
fatal and potential serious errors were in accordance with 
international definitions of potential (ADEs) [15, 16]. The 
principal investigator and one internist classified these 
errors in these four categories.
Operational definitions
Prescribing error Implies deviation of medication pre-
scribing from standard practices (as indicated in standard 
treatment guidelines, textbooks, and software) excluding, 
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indication without drug, dosage form errors, illegible 
hand writing, and failure to authenticate the prescription 
with signature and/or date.
Poly‑pharmacy: the use of five or more regular medications 
at a time
Wrong combination Implies therapeutic duplications and 
clinically significant drug interactions.
Omission error Implies medications ordered without 
specifying dose, frequency, and route.
Wrong indication Implies the presence of inappropriate 
drug and contraindications which were not noted by the 
prescribing physician.
Ethical considerations
This study was approved by Ethical review board of 
School of pharmacy, Addis Ababa University (ERB/
SOP/28/05/2013). The collected data was used exclu-




This study included 882 physician drug prescription epi-
sodes for 220 patients who were admitted to the medical 
ICU of TASH during the 1 year period in 1311 patient-
days. Several prescriptions did not contain information 
such as drug allergy history and/or weight of patient and 
were excluded from definition of prescribing error.
Out of 220 patient cards, 120 (54.5  %) were male 
patients. The age profile showed that only 13 (5.91  %) 
patients were below the age of 18  years; 136 patients 
(61.8 %) were between 18 and 50 years and 71 (32.27 %) 
patients were over 50  years of age and the mean age of 
41.34 (±17.7)  years. 168 (76.36  %) of them were admit-
ted to medical ICU directly from emergency outpatient 
department (EOPD). 161 (73.2  %) of the patients were 
conscious and 187 (85 %) were having a prescription with 
poly-pharmacy, with the average number of medications 
per patient being 8.8 (±3.81) drugs. The median length of 
stay in the ICU was 5 (1–27) days until death or transfer 
to other wards, and the average diagnosis per patient was 
3.29 (±.44) (Table 1).
Identification of medication‑related events
Of the 882 prescription episodes, approximately 26.42 % 
orders had at least one medication error. The majority of 
orders were having one error per order which occurred 
in 148 (16.78 %) orders, followed by two errors per order 
44 (4.9 %), three errors per order occurs in 31 (3.51 %), 
four errors in 5 (0.57 %), five errors in 2 (0.23 %) orders. 
The total number of errors identified was found to be 
359, which accounts error prevalence of 40.7/100 orders. 
The prescribing errors were classified according to the 
types of errors and the medication class involved.
Out of the total errors detected, omission errors were 
noted 154 (42.89 %) of the total errors identified making 
it the top most medication error. This was followed by 
wrong combination in 101 (28.13 %) cases, 48 (13.37) % 
wrong abbreviation. The detailed distribution of the 
medication errors is shown in Table 2.
The analysis of medication errors identified per medi-
cation class showed that the cardiovascular agents 
contributing maximum (33.9  %), this was followed by 
antimicrobial agents (20.49  %). Approximately 80  % of 
the total errors occurred in cardiovascular, antimicrobial 
and gastrointestinal agents (Table 3).
It is evident that the total number of times a medication 
class was involved in the errors (410) was higher than the 
total number of errors identified (359). This implies that 
in one error, two or more medications might be involved 
belonging to either the same or different class (Table 3).
Sixty-nine drugs were related to prescribing errors. The 
top five drugs with high incidence of medication error 
included; cimetidine 48 (11.71  %) of which 31 (7.56  %) 
were drug interactions and 17 (4.15  %) were duplica-
tion errors. Followed by clopidogrel with an error rate 
of 41 (10 %), in which all of them were drug interactions. 
In the third rank was Omeprazole 20 (4.88 %) of which 
Table 1 Epidemiological and clinical characteristics of the 
study patients at  Tikur Anbessa Specialized Hospital, 
Addis Ababa, Ethiopia (n = 220)
Dx diagnosis
a A patient was directly admitted to ICU from emergency
Characteristics Frequency (%)
Age
<18 13 (5.9 %)
18–50 136 (61.82 %)
>50 71 (32.27 %)
Sex
Male 120 (54.5 %)
Female 100 (45.5 %)
State of patient
Conscious 161 (73.2 %)
Unconscious 59 (26.8 %)
Regimen taken
Poly-pharmacy 187 (85 %)
Simple 33 (15 %)
Source of admission
Emergencya 168 (76.36 %)
Other ward 52 (23.64 %)
Median length of stay in ICU 5 (1–27) days
The average no. of Dx/patient 3.29 (+1.44)
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19 (4.63  %) were drug interactions and 1 (0.24  %) was 
duplication error, followed by dopamine 19 (4.63 %), 18 
(4.39 %) of them were omission errors and only 1 (0.24 %) 
was dose error and tramadol with error rate of 18 
(4.39 %), 16 (3.9 %) of them were duplication errors and 2 
(0.49 %) were wrong dose errors. More than one-third of 
the total error occurred in these five drugs (35.6 %).
The evaluation of potential consequences of prescrib-
ing errors indicated that the majority of the errors were 
non-significant (67.4 %) and no fatal error was detected 
(Table 4).
Factors associated with prescribing errors
The binary logistic regression analysis showed that 
there was statistically significant association between 
prescribing error and age >50  years (p  =  0.003) and 
18–50  years (p =  0.004). The odds of these age groups 
[OR = 10.771 (2.208–52.546) and 9.765 (2.079–45.861)] 
respectively revealed that the probability of error in the 
age group >50 years is 10.771 times higher than patients 
with age <18 years. Poly-pharmacy was also significantly 
associated with error rate with (p = 0.000) and odds ratio 
[OR = 5.644 (2.473–12.884)].
The error rate in patients getting poly-pharmacy was 
5.644 times higher than in patients getting simple regi-
men. The odds of both age and poly-pharmacy were large 
enough (>3) indicating that there was strong association 
with error rate. Male gender (p = 0.019) and admission 
from other wards (p = 0.029) were also found to be sig-
nificantly associated with error rate. The odds of these 
factors were (OR = 1.553 and 1.889) respectively showed 
there was moderate association with error rate. Whereas, 
state of patient at admission, duration of ICU stay and 
number of co-morbidities were not significantly associ-
ated with prescribing error (Table 5).
Sample examples of different types of prescribing 
errors (omission, wrong combination, wrong dose, fre-
quency and wrong indication) detected in the present 
study are indicated in Table 6.
Discussion
In the present study, prescribing errors were investigated 
in the medical ICU of TASH. The higher prevalence of 
these errors (40.7 %) in the prescribing process indicated 
a need for improvement in ordering stage of the medi-
cation use process. None of the errors identified were 
fatal, but approximately one-third was assessed as being 
potentially significant or serious.
The rate of prescribing errors found in this study 
(40.7  %) is a relatively low frequency compared to the 
results of a recent study done in medical ICU of Jimma 
University Specialized Hospital (JUSH) involving 69 
patients with error rate of 52.5  % [4]. Whereas, com-
paring this result with those from a study by Bates et al. 
[16], using observational method in an adult patient 
Table 2 Frequency (%) of  medication prescription error 
categories in  Tikur Anbessa Specialized Hospital, Addis 
Ababa, Ethiopia
Error type Frequency (%)
Dose omission 33 (9.19 %)
Frequency omission 58 (16.15 %)
Route omission 63 (17.54 %)
Omission error (subtotal) 154 (42.89 %)
Drug interaction 57 (15.87 %)
Duplication 44 (12.26 %)
Wrong combination (subtotal) 101 (28.13 %)
Wrong abbreviation 48 (13.37 %)
Over dose 14 (3.89 %)
Under dose 16 (4.46 %)
Wrong dose (subtotal) 30 (8.36 %)
Wrong frequency 18 (5.01 %)
Wrong indication 8 (2.23 %)
Total 359 (100 %)
Table 3 Therapeutic category of  medications with  pre-
scribing errors at  Tikur Anbessa Specialized Hospital, 
Addis Ababa, Ethiopia
a Bronchodilators, minerals, vitamins, drugs of autonomic nervous system, 
electrolytes
Drug category Frequency (%)
Cardiovascular drugs 139 (33.90 %)
Antimicrobials 84 (20.49 %)
GI drugs 77 (18.78 %)
Opioid 34 (8.29 %)
CNS drugs 33 (8.05 %)
Analgesic and sedatives 21 (5.12 %)
Miscellaneousa 22 (5.37 %)
Total 410 (100 %)
Table 4 Potential clinical consequences of  prescribing 
errors detected at  Tikur Anbessa Specialized Hospital, 
Addis Ababa, Ethiopia
Clinical consequences Frequency (%)
Potentially fatal –
Potentially serious 6 (1.7 %)
Potentially significant 111 (30.9 %)
Potentially non-significant 242 (67.4 %)
Total 359 (100 %)
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population, our study had a higher rate of medication 
errors (40 errors/100 orders in our study versus 5.3/100 
orders). In an observational study conducted in Moroc-
can medical ICU, the error rate was 10/100 orders [17], 
Iran (35.1  %) [2] and the study in Brazil showed 7.47  % 
error rate [10], the rate in our study is still higher. 
Whereas the error prevalence in the current study is 
comparable with the study in Denmark (41 %) [15].
The systematic review of ME incidence in differ-
ent ICU types [8], have found a wide variation in 
reported rates of MEs. The difference could be due to 
differences in definitions of errors, methods used to 
detect errors, level and type of ICUs, level of prescrib-
ing physicians and availability of facilities for patient 
care. However, the higher frequency of errors in the 
ICU of TASH even after excluding errors related 
with illegible hand writing, indications without drug, 
lack of authentication, and dosage form might be 
related to absence of a pharmacist in the health care 
team, absence of a closed-loop electronic prescribing 
Table 5 Frequency (%) of medication prescription errors according to potential risk factors at Tikur Anbessa Specialized 
Hospital, Addis Ababa, Ethiopia
Characteristics Number of patients No. of patients with error % of patients with error P‑value Ex(B) (95 % CI)
Age
 <18 13 2 15.4 –
 18–50 136 87 64.0 0.004 9.765 (2.079–45.861)
 >50 71 47 66.2 0.003 10.771 (2.208–52.546)
Gender
 Male 120 73 60.8 0.019 1.553
 Female 100 63 63.0 – 1.096 (0.634–2.124)
Regimen taken
 Poly pharmacy 187 127 67.6 0.000 5.644 (2.473–12.884)
 Simple 33 9 27.3 – 0.375
Co-morbidity
 <3 75 41 54.7 – 1.206
 ≥3 145 95 65.5 0.117 1.576 (0.892–2.784)
State of patient
 Conscious 161 101 62.7 – 1.458
 Unconscious 59 35 59.3 0.645 1.154 (0.627–1.894)
Source of admission
 Emergency 168 102 60.7 – 0.818 (0.427–1.567)
 Other wards 52 34 65.4 0.029 1.889
Length of ICU stay
 <4 days 79 43 54.4 – 1.194
 ≥4 days 141 93 66.0 0.092 1.622 (0.923–2.849)
Table 6 Examples of medication prescribing errors at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
Faulty use of medications detected
Tramadol 50 mg IV TID was prescribed with morphine 30 mg po BID and pethidine 50 mg IV TID where one/two of these drugs is enough (duplication 
error)
Nimodipine was initially prescribed on three times daily(TID) basis instead of Q4 h (wrong frequency)
A patient with peptic ulcer disease (PUD) was initially taking esomeprazole 20 mg IV bid was given cimetidine 200 mg IV bid and ranitidine 50 mg IV bid 
where one drug is enough (duplication error)
Tramadol 500 mg IV TID was prescribed for 66 years old patient to control pain, instead of 50 mg IV TID (wrong dose)
Forgot to define the route of administration of heparin as IV or SC (omission error)
Forgot to define the dose of dopamine (omission error)
Mannitol 25 mg IV QID was prescribed as a maintenance dose for 50 kg patient with increase ICP, instead of 25 g IV QID (wrong dose)
Captopril was prescribed for a patient with hyperkalemia (k:5.3) to control hypertension (wrong indication)
Hydrochlorothiazide was abbreviated as Hct (wrong abbreviation)
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mechanism, and lack of required medical facilities in 
the ICU.
Concerning the error types, the most common types 
of medication prescribing errors were omission of dose/
frequency/route (42.89  %), the wrong combination of 
drugs (28.13 %) of which 57 (15.88 %) were drug interac-
tions and 44 (12.26  %) duplication errors, wrong abbre-
viations (13.37 %), dose error [8.36 %; over dose (3.89 %) 
and under dose (4.46  %)], wrong frequency (5.01  %) and 
wrong indication (2.23  %). The present study indicated 
that, omission and combination errors account for about 
71 % of the total error types. This result is higher than the 
finding of the study from Jimma (49.5 %) [4]. High number 
of omission and combination errors might be attributed 
to documentation problem, high turnover of prescription 
episodes and absence of any system to support prescribing 
physicians, who usually rely on their memory. According 
to the current study, the three most common categories of 
drugs encountered in prescribing errors were cardiovascu-
lar drugs (33.90 %), antimicrobials (20.49 %), and gastro-
intestinal drugs (18.78 %). High incidence of error in these 
drug classes might be due to frequent prescription of these 
drugs. This finding was different from what was reported 
from UK, where cardiovascular 24.2 %, followed by blood 
and nutrition 19.9 %, CNS 16.1 %, infection 12.5 %, anes-
thesia 9.4 %, gastro-intestinal 5.3 % and endocrine agents 
4.1  % [17]. The frequency of errors associated with gas-
tro-intestinal drugs (20.49 %) was quite high in this study 
unlike the UK’s finding (5.3  %) and there were no errors 
recorded in relation to wrong route of administration. The 
difference in the error rate between drug classes might be 
attributed to differences in the types of cases admitted to 
the ICU and co-morbid conditions in the patients.
In the UK study percentage of drugs incorrectly pre-
scribed was 9.4 % [17] unlike our study which is 21.5 %. 
This variation is probably due to the difference in the 
study set up where, the UK’s study is multi-centered. But, 
our result is comparable with the Brazilian study (20.2 %) 
[10]. The top five drugs with high error rate are different 
from those of UK’s study. The five most common incor-
rect prescriptions were for cimetidine 48 (11.71 %), clopi-
dogrel 41 (10  %), omeprazole 20 (4.88  %), dopamine 19 
(4.63 %) and tramadol 18 (4.39 %). More than one-third 
of the total error occurred in these five drugs (35.6 %).
The literature review revealed that there are various 
risk factors for high medication error rate in ICU patients 
like, age, gender, number of co-morbidities, number of 
drugs prescribed, state of the patient at admission and 
the length of stay in ICU [6]. Our finding is in concur-
rence with other studies in which the error rate is sig-
nificantly associated with poly-pharmacy and age. In 
contrary to other studies, number of co-morbidity, length 
of stay in ICU and state of patient at admission were not 
significantly associated. This might be attributed to dif-
ferent confounding factors.
Our literature review highlighted that potential strate-
gies to prevent medication errors in the ICU are focused 
on seven prevention strategies: eliminating extended 
physician work schedules, computerizing physician order 
entry, implementing support systems for clinical deci-
sions, computerizing intravenous devices, and having 
pharmacists participate in the ICU, reconciling medica-
tions and standardizing medications [7].
The practical approach is to recognize that errors are a 
reality of medicine and that all health care providers have 
a responsibility to ensure patient safety and to use cau-
tion in promoting interventions. Improved medication 
safety may be accomplished by optimizing the safety of 
the medication process, eliminating situational risk fac-
tors and adopting strategies to intercept errors and miti-
gate their consequences.
Finally, it should be noted that errors during prescrip-
tion writing process due to documentation problem 
might have been intercepted by prescribing physician 
with informal/oral communication with the nurse. The 
use of guidelines rather than clinical opinions to deter-
mine error must also be noted.
This study has certain limitations; it was a retrospective 
study and suffers from all shortcomings of retrospective 
study, the scope of the study was limited to prescribing 
errors, the study hospital was a teaching hospital and sin-
gle-centered study so that it will affect its generalize abil-
ity to other general hospitals and the scope of the study 
was limited to prescribing errors and didn’t assess other 
components of medication errors, so the finding should 
be interpreted with caution.
Conclusions
The present study establishes that prescribing errors were 
highly prevalent in the ICU of TASH. The errors reported 
in this study clearly show that there are multiple causes 
for prescribing errors in the ICU of TASH. Approxi-
mately one-third of the errors were potentially signifi-
cant. Omission errors are the most common followed by 
wrong combination errors. Cardiovascular drugs were 
the classes with high error rate followed by antimicrobi-
als. Age and poly-pharmacy were the strongest predic-
tors of prescribing error. These results can be used to 
improve quality of health care delivery. Hospital man-
agers should strive to create better awareness about the 
possibility of medication errors at the prescribing phase 
among health care professionals. Further prospective 
study involving other components of medication error is 
also recommended.
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